William Blair Brokers Increase Earnings Estimates for Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (NYSE:IQV) – Equities research analysts at William Blair increased their Q1 2018 earnings per share estimates for Iqvia in a research note issued to investors on Thursday. William Blair analyst J. Kreger now forecasts that the medical research company will earn $1.24 per share for the quarter, up from their prior estimate of $1.19. William Blair also issued estimates for Iqvia’s Q2 2018 earnings at $1.32 EPS and FY2020 earnings at $7.26 EPS.

Iqvia (NYSE:IQV) last posted its quarterly earnings results on Thursday, October 26th. The medical research company reported $1.19 EPS for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.05. Iqvia had a return on equity of 12.60% and a net margin of 0.58%. The company had revenue of $2.02 billion for the quarter, compared to analysts’ expectations of $2.01 billion. During the same period in the previous year, the firm earned $1.00 EPS. The firm’s revenue was up 77.6% compared to the same quarter last year.

Other research analysts have also recently issued reports about the company. Royal Bank of Canada began coverage on Iqvia in a report on Tuesday, September 19th. They issued an “outperform” rating and a $116.00 price target on the stock. KeyCorp reissued a “buy” rating and issued a $100.00 price target on shares of Iqvia in a report on Sunday, September 24th. Zacks Investment Research raised Iqvia from a “hold” rating to a “buy” rating and set a $114.00 price target on the stock in a report on Saturday, October 21st. Barclays boosted their price target on Iqvia from $100.00 to $120.00 and gave the stock an “overweight” rating in a report on Friday, October 27th. Finally, Stifel Nicolaus raised Iqvia from a “hold” rating to a “buy” rating and boosted their price target for the stock from $92.00 to $128.00 in a report on Friday, October 27th. Nine investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Iqvia has an average rating of “Buy” and a consensus target price of $106.94.

Iqvia (NYSE:IQV) opened at $100.04 on Friday. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.29. Iqvia has a twelve month low of $74.80 and a twelve month high of $110.67. The company has a market capitalization of $20,810.00, a P/E ratio of 344.97, a P/E/G ratio of 1.38 and a beta of 0.61.

In other news, insider James H. Erlinger III sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $101.21, for a total transaction of $1,012,100.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of the business’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $102.00, for a total value of $764,776,314.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,806,558 shares of company stock worth $898,722,108. Corporate insiders own 6.40% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC bought a new position in shares of Iqvia during the 4th quarter valued at approximately $920,000. First Citizens Bank & Trust Co. bought a new position in shares of Iqvia during the 4th quarter valued at approximately $1,067,000. Bremer Trust National Association bought a new position in shares of Iqvia during the 4th quarter valued at approximately $1,445,000. Exxonmobil Investment Management Inc. TX bought a new position in shares of Iqvia during the 4th quarter valued at approximately $2,266,000. Finally, Sheets Smith Wealth Management bought a new position in shares of Iqvia during the 4th quarter valued at approximately $5,770,000. 95.78% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This article was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this article on another publication, it was illegally stolen and republished in violation of United States & international copyright and trademark law. The correct version of this article can be read at https://www.com-unik.info/2018/01/13/william-blair-brokers-increase-earnings-estimates-for-iqvia-holdings-inc-iqv.html.

Iqvia Company Profile

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit